Effects of solvents on in vitro potencies of platinum compounds
- 5 October 2011
- journal article
- other
- Published by Elsevier BV in DNA Repair
- Vol. 10 (11), 1084-1085
- https://doi.org/10.1016/j.dnarep.2011.09.008
Abstract
No abstract availableKeywords
Funding Information
- Susan G. Komen for the Cure (FAS0703858, R31-10069)
- National Research Foundation of Korea
- Ministry of Education, Science and Technology
This publication has 9 references indexed in Scilit:
- Cell death assays for drug discoveryNature Reviews Drug Discovery, 2011
- A Better Platinum-Based Anticancer Drug Yet to Come?Anti-Cancer Agents in Medicinal Chemistry, 2010
- Stability of Oxaliplatin SolutionAnnals of Pharmacotherapy, 2009
- Platinum compounds 30 years after the introduction of cisplatin: Implications for the treatment of ovarian cancerGynecologic Oncology, 2009
- Physical and chemical stability of palonosetron HCl with cisplatin, carboplatin, and oxaliplatin during simulated Y-site administrationJournal of Oncology Pharmacy Practice, 2004
- Loss of in vitro cytotoxicity of cisplatin after storage as stock solution in cell culture medium at various temperatures.1997
- Loss of in vitro cytotoxicity of cisplatin after storage as stock solution in cell culture medium at various temperaturesCancer, 1997
- Stability of cisplatin in sodium chloride 0.9% intravenous solution related to the container's materialInternational Journal of Clinical Pharmacy, 1993
- Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.1987